Dry powder inhalation; ipratropium bromide; horse; drug delivery
Abstract :
[en] The aim of this study was to determine the effect of breathing pattern, air humidity and position of the device on the delivery of an aerosol generated by a dry powder inhalation (DPI) device (Inhalator M). The in vitro inhalation study was performed using the cascade impaction method (Andersen Sampler) adapted to imitate nasal breathing. The amount of ipratropium found in the device, the artificial upper airways and the six stages of the Andersen Sampler was measured using high precision liquid chromatography. Stage 1 of the Andersen Sampler was considered to be the respirable fraction and stages 2 to 6 to be the non-respirable fraction. It was concluded that the theoretical respirable fraction of ipratropium obtained after DPI through Inhalator M was influenced by relative air humidity, air flow and the position of the device, whereas the number of successive inspirations and the duration of inspiration did not affect this fraction of the drug.
Disciplines :
Veterinary medicine & animal health Anatomy (cytology, histology, embryology...) & physiology
Author, co-author :
Duvivier, Dominique Hannia; Université de Liège - ULiège > Faculté de médecine vétérinaire > Physiologie
Chiap, Patrice ; Université de Liège - ULiège > Département de pharmacie > Analyse des médicaments
Crommen, Jacques ; Université de Liège - ULiège > Département de pharmacie > Analyse des médicaments
Lekeux, Pierre ; Université de Liège - ULiège > Département de sciences fonctionnelles > Physiologie
Language :
English
Title :
Evaluation of some parameters influencing the drug delivery from a dry powder inhalation device using an in vitro model of the horse airways
Barone R (1984) Anatomie comparée des mammifères domestiques. 2nd ed, vol 3. Splanchnologie I, 2ème partie: appareil respiratoire. Vigot
Bell JH, Hartley PS, Cox JSG (1971) Dry powder aerosols I: a new powder inhalation device. J Pharm Sci 60, 1559-1564
Clarke SW, Pavia D (1988) Defense mechanisms, and immunology, deposition and clearance. In: Text- book of Respiratory Medicine (JA Nadel, ed), WB Saunders Co, Philadelphia, 313
Clarke AF (1991) Practicalities of nebulisation. Equine Vet Educ 3, 45-49
Corr D, Dolovich M, McCormack D, Ruffin R, Obminski G, Newhouse M (1982) Design and characteristics of a portable breath-actuated particle size selective medical aerosol inhaler. J Aerosol Sci 13, 1-7
Dickens CJ, McAughey JJ, Knight DA, Baker ST (1994) Factors affecting in vitro testing inhalers. J Aerosol Med 7, 193-196
Dolovich M, Ruffin R, Corr D, Newhouse MT (1983) Clinical evaluation of a simple demand inhalation MDI aerosol delivery device. Chest 84, 36-41
Duvivier DH, Votion D, Vandenput S, Art T, Lekeux P (1997) Technical validation of the dry powder inhalation in the equine species. Equine Vet J (in press)
Ganderton D (1995) In vitro testing of inhalation products. In Proceedings: Drug Delivery to the Lungs VI. The Aerosol Society, 85-88
Greenough A, Yuksel B, Everett L, Price JF (1993) Inhaled ipratropium bromide and terbutaline in asthmatic children. Respir Med 87, 111-114
Hallworth GN, Andrews UG (1976) Size analysis of suspension inhalation aerosols by inertial separation methods. J Pharm Pharmacol 28, 898-907
Jacobson GA, Peterson GM (1994) High-performance liquid chromatographic assay for the simultaneous determination of ipratropium bromide, fenoterol, salbutamol and terbutaline in nebulizer solution. J Pharm Biomed Analysis 12, 825-832
Jashnani RN, Byron PR, Dalby RN (1995) Testing of dry powder aerosol formulations in different environmental conditions. Int J Pharm 113, 123-130
Lekeux P, Art T (1994) The respiratory system: anatomy, physiology, and adaptations to exercise and training In: Principles and Practice of Equine Sports Medicine: The Athletic Horse (DR Hodgson, RJ Rose, ed). Saunders, Philadelphia, 79-127
Melandri C, Prodi V, Tarroni G, Formingani M, De Zaiacomo T, Bompane GF, Maestri G (1977) On the deposition of unipolary charged particles in the human respiratory tract. In: Inhaled Particles IV (Walton WH, ed), Pergamon, Oxford, 193-201
Mitchell RK (1960) Retention of aerosol particles in the respiratory tract. Am Rev Respir Dis 82, 627-639
Morrow PE (1986) Factors determining hygroscopic aerosol deposition in airways. Physiol Rev 66, 330-376
Newman SP, Moren F, Trofast E, Talae N, Clarke SW (1989) Deposition and clinical efficacy of terbutaline sulphate from Turbuhaler, a new multi-dose powder inhaler. Eur Respir J 2, 247-252
Newman SP, Hollingworth A, Clark AR (1994) Effect of different modes of inhalation on drug delivery from a dry powder inhaler. Int J Pharm 102, 127-132
Onyechi JO, Martin GP, Marriott C, Murphy L (1994) Deposition of dry powder aerosols in cascade impactors at different flow rates. J Aerosol Med 7, 181-184
Pakes GE, Brogden RN, Heel RC, Speight TM, Avery GS (1980) Ipratropium bromide: a review of its pharmacological properties and therapeutic efficacy in asthma and chronic bronchitis. Drugs 20, 237-266
Robinson NE, Derksen FJ, Berney C, Goossens L (1993) The airway response of horses with recurrent airway obstruction (heaves) to aerosol administration of ipratropium bromide. Equine Vet J 25, 299-303
Timsina MP, Martin GP, Marriott C, Lee KC, Suen KO, Yianneskis M (1993) Studies on the measurement of peak inspiratory flow rate with dry powder inhaler devices in healthy volunteers. Thorax 48, 433
Timsnia MP, Martin G, Marriott C, Ganderton D, Yianneskis M (1994) Drug delivery to the respiratory tract using dry powder inhalers. Int J Pharm 101, 1-13
Vidgren M, Karkkainen A, Karjalainen P, Nuutinen J, Paronen P (1988a) In vitro and in vivo deposition of drug particles inhaled from pressurized aerosol and dry powder inhaler. Drug Dev Ind Pharm 14, 2649-2665
Vidgren M, Karkkainen A, Karjalainen P (1988b) Effect of powder inhaler design on drug deposition in the respiratory tract. Int J Pharm 42, 211-216